BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 16181551)

  • 1. [SHP2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion].
    He HY; Zheng J; Li Y; Heng WJ; Fang WG
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):288-92. PubMed ID: 16181551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of the mitogen-activated protein kinase phosphatase-5 regulating the growth and invasion of a human prostate cancer cell line].
    He HY; Fang WG; Zheng J; You JF; Heng WJ; Li Y
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1812-7. PubMed ID: 14642090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of P2Y receptor activation on prostatic cancer cells requiring ERK1/2 or p38 cascade].
    Chen L; Fang WG; Heng WJ; You JF
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):146-50. PubMed ID: 15132853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ERK1/2 and p38 kinases are important regulators in P2Y receptor-mediated prostate cancer invasion].
    Chen L; He HY; Li HM; You JF; Heng WJ; Li Y; Fang WG
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):111-4. PubMed ID: 15774218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of p38 and c-Jun NH2-terminal kinase mitogen-activated protein kinases in human prostate carcinoma cell lines with different metastatic potentials].
    Li H; Fang W; He C; You J; Heng W; Zheng J; Wu B
    Zhonghua Bing Li Xue Za Zhi; 2001 Jun; 30(3):194-7. PubMed ID: 11866977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of the activation of extracellular signal-regulated kinase (ERK) in prostate cancer cell lines with different metastatic potential].
    Li H; He C; Zheng J
    Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(4):197-200. PubMed ID: 11798872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D.
    Nonn L; Peng L; Feldman D; Peehl DM
    Cancer Res; 2006 Apr; 66(8):4516-24. PubMed ID: 16618780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK1/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion.
    Chen L; He HY; Li HM; Zheng J; Heng WJ; You JF; Fang WG
    Cancer Lett; 2004 Nov; 215(2):239-47. PubMed ID: 15488643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [P2Y purinergic receptor activated PI-3K/Akt signaling pathway in regulation of growth and invasion of prostatic cancer].
    Wang YX; Shi YH; Gong LH; Li Y; Heng WJ; You JF; Zhong HH; Fang WG
    Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):681-6. PubMed ID: 18194602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
    Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of vimentin on invasion and metastasis of prostate cancer cell lines PC-3M-1E8 and PC-3M-2B4].
    Wei JC; Wu MF; Zhang YT; Zhao LP; Lu YP; Ma D
    Ai Zheng; 2008 Jan; 27(1):30-4. PubMed ID: 18184460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of ERK1/2 by extracellular nucleotides in macrophages is mediated by multiple P2 receptors independently of P2X7-associated pore or channel formation.
    da Cruz CM; Ventura AL; Schachter J; Costa-Junior HM; da Silva Souza HA; Gomes FR; Coutinho-Silva R; Ojcius DM; Persechini PM
    Br J Pharmacol; 2006 Feb; 147(3):324-34. PubMed ID: 16341234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.
    Wang Z; Yang H; Tachado SD; Capó-Aponte JE; Bildin VN; Koziel H; Reinach PS
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5267-75. PubMed ID: 17122112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1/2 signaling.
    Krenz M; Yutzey KE; Robbins J
    Circ Res; 2005 Oct; 97(8):813-20. PubMed ID: 16166557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular ATP counteracts the ERK1/2-mediated death-promoting signaling cascades in astrocytes.
    Shinozaki Y; Koizumi S; Ohno Y; Nagao T; Inoue K
    Glia; 2006 Nov; 54(6):606-18. PubMed ID: 16944453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of ERK 1/2 and p38 MAPK signaling pathways by ATP in osteoblasts: involvement of mechanical stress-activated calcium influx, PKC and Src activation.
    Katz S; Boland R; Santillán G
    Int J Biochem Cell Biol; 2006; 38(12):2082-91. PubMed ID: 16893669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P2Y receptor-mediated stimulation of Müller glial cell DNA synthesis: dependence on EGF and PDGF receptor transactivation.
    Milenkovic I; Weick M; Wiedemann P; Reichenbach A; Bringmann A
    Invest Ophthalmol Vis Sci; 2003 Mar; 44(3):1211-20. PubMed ID: 12601051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular ATP activates MAP kinase cascades through a P2Y purinergic receptor in the human intestinal Caco-2 cell line.
    Buzzi N; Bilbao PS; Boland R; de Boland AR
    Biochim Biophys Acta; 2009 Dec; 1790(12):1651-9. PubMed ID: 19836435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.
    Samayawardhena LA; Hu J; Stein PL; Craig AW
    Cell Signal; 2006 Sep; 18(9):1447-54. PubMed ID: 16442778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
    Givant-Horwitz V; Davidson B; Reich R
    Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.